A therapeutic shoe designed to improve stroke survivors’ gait and symmetry was successful in a small-scale trial of six patients, according to a study published in the Journal of NeuroEngineering and Rehabilitation.

Research presented at the American Heart Association’s Hypertension 2019 Scientific Sessions this month suggests having high blood pressure speeds up cognitive decline in middle-aged and older adults—but treating the condition can reverse that possibility.

New research suggests the incidence of cardiac amyloidosis in the U.S. is trending up, bringing with it high rates of morbidity and mortality.

Research out of UT Southwestern Medical Center in Dallas suggests at-home blood pressure monitoring is a more accurate approach to CV risk prediction in black patients.

A singular, high-dose beam of radiation could improve survival odds in patients with ventricular tachycardia, many of whom are too sick to undergo conventional therapy, researchers reported at the ASTRO meeting in Chicago Sept. 15.

The incidence of aborted procedures during transcatheter aortic valve replacement is falling, according to work published in JACC: Cardiovascular Interventions, but centers with low institutional TAVR volume still struggle to keep up with bigger hospitals’ success.

Drugmaker Novartis is halting the distribution of generic Zantac, or ranitidine, while the drug is investigated for NDMA, a probable human carcinogen.

Radiation boosts the immune system of patients with metastatic non-small-cell lung cancer (NSCLC) after they stop responding to immunotherapy, according to findings presented at the 2019 annual meeting of the American Society for Radiation Oncology (ASTRO).